126 related articles for article (PubMed ID: 36336138)
21. Blood‒Brain Barrier Pathology and CNS Outcomes in
Yau B; Hunt NH; Mitchell AJ; Too LK
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423890
[No Abstract] [Full Text] [Related]
22. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
[TBL] [Abstract][Full Text] [Related]
23. CD93/AA4.1: a novel regulator of inflammation in murine focal cerebral ischemia.
Harhausen D; Prinz V; Ziegler G; Gertz K; Endres M; Lehrach H; Gasque P; Botto M; Stahel PF; Dirnagl U; Nietfeld W; Trendelenburg G
J Immunol; 2010 Jun; 184(11):6407-17. PubMed ID: 20439917
[TBL] [Abstract][Full Text] [Related]
24. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
Ikewaki N; Yamao H; Kulski JK; Inoko H
J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
[TBL] [Abstract][Full Text] [Related]
26. Regulation of CD93 cell surface expression by protein kinase C isoenzymes.
Ikewaki N; Kulski JK; Inoko H
Microbiol Immunol; 2006; 50(2):93-103. PubMed ID: 16490927
[TBL] [Abstract][Full Text] [Related]
27. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
Bohlson SS; Silva R; Fonseca MI; Tenner AJ
J Immunol; 2005 Jul; 175(2):1239-47. PubMed ID: 16002728
[TBL] [Abstract][Full Text] [Related]
28. CD93 is Selectively Expressed on Human Myeloma Cells but Not on B Lymphocytes.
Fakhari S; Bashiri H; Ghaderi B; Tari K; Jalili A
Iran J Immunol; 2019 Jun; 16(2):142-150. PubMed ID: 31182688
[TBL] [Abstract][Full Text] [Related]
29. Integrin expression on neutrophils in a rabbit model of Group B Streptococcal meningitis.
Rowin ME; Xue V; Irazuzta J
Inflammation; 2000 Apr; 24(2):157-73. PubMed ID: 10718117
[TBL] [Abstract][Full Text] [Related]
30. RNA interference-mediated silencing of DNA methyltransferase 1 attenuates neuropathic pain by accelerating microglia M2 polarization.
Tan Y; Wang Z; Liu T; Gao P; Xu S; Tan L
BMC Neurol; 2022 Oct; 22(1):376. PubMed ID: 36183073
[TBL] [Abstract][Full Text] [Related]
31. Unique properties of cluster of differentiation 93 in the umbilical cord blood of neonates.
Ikewaki N; Sonoda T; Inoko H
Microbiol Immunol; 2013 Dec; 57(12):822-32. PubMed ID: 24033555
[TBL] [Abstract][Full Text] [Related]
32. Potential of serum soluble CD93 as a biomarker for asthma in an ovalbumin-induced asthma murine model.
Park HJ; Oh EY; Park YH; Yang M; Park KH; Park JW; Lee JH
Biomarkers; 2018 Jul; 23(5):446-452. PubMed ID: 29498549
[TBL] [Abstract][Full Text] [Related]
33. β1-integrin-dependent migration of microglia in response to neuron-released α-synuclein.
Kim C; Cho ED; Kim HK; You S; Lee HJ; Hwang D; Lee SJ
Exp Mol Med; 2014 Apr; 46(4):e91. PubMed ID: 24743837
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of CD93 exacerbates inflammation-induced activation and migration of BV2 microglia by regulating the TAK1/NF-κB pathway.
Hong X; Xia M; Zhang Q; Zhao T; Zhang Y; Qian Z; Bao J; Li H
Neurosci Lett; 2022 Nov; 791():136914. PubMed ID: 36270452
[TBL] [Abstract][Full Text] [Related]
35. Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies.
Lee M; Park HS; Choi MY; Kim HZ; Moon SJ; Ha JY; Choi A; Park YW; Park JS; Shin EC; Ahn CW; Kang S
J Clin Med; 2020 May; 9(5):. PubMed ID: 32397261
[TBL] [Abstract][Full Text] [Related]
36. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis.
Bohlson SS; Zhang M; Ortiz CE; Tenner AJ
J Leukoc Biol; 2005 Jan; 77(1):80-9. PubMed ID: 15459234
[TBL] [Abstract][Full Text] [Related]
37. B7-H3 Augments Inflammatory Responses and Exacerbates Brain Damage via Amplifying NF-κB p65 and MAPK p38 Activation during Experimental Pneumococcal Meningitis.
Chen X; Li Y; Blankson S; Liu M; Huang D; Redmond HP; Huang J; Wang JH; Wang J
PLoS One; 2017; 12(1):e0171146. PubMed ID: 28141831
[TBL] [Abstract][Full Text] [Related]
38. Loss of IL-10 Promotes Differentiation of Microglia to a M1 Phenotype.
Laffer B; Bauer D; Wasmuth S; Busch M; Jalilvand TV; Thanos S; Meyer Zu Hörste G; Loser K; Langmann T; Heiligenhaus A; Kasper M
Front Cell Neurosci; 2019; 13():430. PubMed ID: 31649508
[TBL] [Abstract][Full Text] [Related]
39. Modulated interaction of the ERM protein, moesin, with CD93.
Zhang M; Bohlson SS; Dy M; Tenner AJ
Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698
[TBL] [Abstract][Full Text] [Related]
40. Uncovering the neuroprotective effect of vitamin B12 in pneumococcal meningitis: insights into its pleiotropic mode of action at the transcriptional level.
Cassiano LMG; Oliveira MDS; de Queiroz KB; Amancio AMTDS; Salim ACM; Fernandes GDR; Carneiro CM; Coimbra RS
Front Immunol; 2023; 14():1250055. PubMed ID: 37854591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
